Trial Profile
Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Bicalutamide; Dexamethasone; Estramustine; Goserelin
- Indications Prostate cancer
- Focus Therapeutic Use
- 13 Aug 2012 Actual end date May 2011 added as reported by ClinicalTrials.gov.
- 13 Aug 2012 Actual initiation date Jan 2001 added as reported by ClinicalTrials.gov.
- 08 Dec 2010 New trial record